CNBC World

AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports

U.K. pharmaceutical giant AstraZeneca is considering a deal to merge with its U.S. rival Bristol Myers Squibb.

This is a short WorldPing brief. The full report was published by CNBC World.

Read the full report at CNBC World

Related news

AstraZeneca holds talks with US cancer drug developer in $400bn mergerWorldPing
The Guardian

AstraZeneca holds talks with US cancer drug developer in $400bn merger

Bristol Myers Squibb tie-up would be one of biggest-ever pharma deals and create world’s fourth-largest drugmaker Business live – latest updates Britain’s biggest drugmaker, AstraZeneca, is understood to be in discussions to take over its US rival Br…

Brief by WorldPing · Original reporting by The Guardian

What’s at stake in the latest U.S.-Iran talks?WorldPing
The Hindu

What’s at stake in the latest U.S.-Iran talks?

What are the key agreements that may shape the next round of Iran-U.S. talks on Monday? With uncertainty looimg large due to Iran’s rebuttal, here are the key sticking points that might determine the Iran-U.S.talks…

Brief by WorldPing · Original reporting by The Hindu